Working in Teams: Data and Communication

Activity: 103rd Annual Meeting
*James Jaggers Moderator
Children's Hospital of Colorado
Aurora, CO 
United States
 - Contact Me

Dr. Jaggers serves as Professor of Surgery, Bartin Elliman Chair of Pediatric Cardiac surgery and Program Director for the Congenital Cardiac Surgery at  The Childrens Hospital Colorado.    Prior to this, Dr Jaggers was Associate Professor of Surgery and  Chief of Congenital Cardiac surgery at Duke University Medical Center.  He is a member of the AATS since 2003 and multiple other medical societies.   He has nearly 200 peer reviewed journal articles and is editor of a major textbook in the care of children with congenital cardiac disease.  

 

 

 

*Jennifer Nelson Moderator
Nemours Children's Health, Florida
Orlando, FL 
United States
 - Contact Me

Dr. Jennifer Nelson is a congenital heart surgeon at Nemours Children's Health in Orlando, FL and Professor of Surgery at the University of Central Florida College of Medicine. Dr. Nelson's clinical interests include surgery for tetralogy of Fallot, aortic valve disease in children and young adults, and Ebstein's anomaly. In addition to publishing on these topics, Dr. Nelson's research focuses on congenital heart surgery outcomes, particularly utilizing the STS National Databases. Dr. Nelson holds several Society leadership positions and recently served as the Chair of the STS Workforce on the Surgical Treatment of Adults with Congenital Heart Disease and led the development of the STS Adult Congenital Heart Disease mortality risk model. She is the former Resident Director to the STS Board of Directors, and currently serves on the Workforce for National Databases. Dr. Nelson is an AATS member and participated in the AATS Congenital Clinical Practice Standards Committee Writing Group on Fast Track Extubation and Postoperative Sedation, and she is the current Chair of the STS Congenital Writing Group composing Clinical Practice Guidelines for Indications and Timing of Pulmonary Valve Replacement Following Repair of Tetralogy of Fallot.

Sunday, May 7, 2023: 7:00 AM - 8:45 AM
Los Angeles Convention Center 
Posted Room Name: 403B 

Track

Congenital
103rd Annual Meeting

Presentations

106. The Journey of Becoming a Congenital Heart Surgeon: Too Long, Too Expensive, Too Unpredictable

Total Time: 15 Minutes 
Objective: The pathway to become a congenital heart surgeon(CHS) is challenging and unpredictable. Previous voluntary manpower surveys have shed partial light on this problem but have not included all trainees. We believe this arduous journey merits more attention.
Methods: To examine the real-life challenges of recent participants in American Council of Graduate Medical Education accredited CHS training programs, we conducted phone interviews with graduates of all 11 approved programs from 2020-2022. This IRB approved survey focused on issues including preparation, length of training, debt burden and employment. Results are presented in n(%) and median(range).
Results: All 22(100%) graduates during the study period were interviewed and were predominantly male(77%), white(64%), married(86%) and have children(77%). (Table) Age at fellowship completion was 37(range: 33-45) years. Individuals were highly accomplished in college and medical school with the majority honors graduates and 33% having additional advanced degrees. Number of peer reviewed manuscripts at completion of training was 20 (range: 5-100). Pathways to fellowship included traditional general surgery with adult cardiac(43%), abbreviated general surgery("4+3", 19%) and integrated-6(38%). For CHS fellowship preparation, 1(5%) underwent visual acuity testing and 0 participated in formal leadership training. Time spent on any pediatric related rotation prior to CHS fellowship was 3(range: 1-7) months. Three(14%) participated in formal pediatric echocardiography or catheterization rotations. Nine(43%) participated in a formal cardiac morphology course. Neonatal cases actually performed as primary surgeon during fellowship was 8(range: 2-25). Debt burden at completion was $179,000(range $0-$550,000). Maximal financial compensation during training before and during CHS fellowship were $65,000(range: $50,000-$100,000) and $80,000(range: $65,000-$165,000) respectively. All are employed - 5(22.7%) as instructors, 13(59.1%) as assistant or associate professors, and 2(9.1%) private practice. Median salary in first job is $450,000(range: $80,000-$700,000). Nine(40.9%) had any financial savings at fellowship completion.
Conclusion: While graduates of CHS fellowships find jobs, individuals are old and compensation is highly variable. Aptitude screening and pediatric focused preparation are minimal. Debt burden is onerous. Further attention to refining training paradigms and compensation are justified. 

View Submission


Invited Discussant

*James O'Brien, Children's Mercy Hospital  - Contact Me Kansas City, MO 
United States

Abstract Presenter

*Charles Fraser, Dell Children's Medical Center  - Contact Me Austin, TX 
United States

Mentoring in Congenital Heart Surgery

Total Time: 15 Minutes 

Speaker

*Emile Bacha, NewYork- Presbyterian/Columbia University Medical Center  - Contact Me New York, NY 
United States

107. Public Reporting of Congenital Cardiac Surgery Outcomes Based on Common Congenital Heart Operations

Total Time: 15 Minutes 
Objective: Ideal reporting of outcomes in congenital heart surgery requires accommodating multiple stakeholders: surgeons, cardiologists, parents, and hospital leadership. The report must be easily understandable and compare homogeneous groups of patients. We sought to develop a system of reporting that can meet these needs.

Methods: For this proof-of-concept project, we selected 19 commonly performed procedures ranging in complexity from the Norwood procedure to repair of atrial septal defects (ASD). To ensure the homogeneity of data and the creation of standard risk cohorts for each of the 19 procedures, we developed strict inclusion and exclusion criteria that encompassed diagnosis, procedure performed, prior interventions, and combination procedures. Preoperative, procedural, and postoperative data were collected for consecutive eligible patients from 8 centers between 1/1/2016 to 12/31/2021. Unadjusted mortality rates (mortality at hospital discharge or within 30 days if discharged home within 30 days) for each of the 19 procedures were analyzed in aggregate and stratified by each center.

Results: A total of 7979 patients were included from 8 centers with the number of cases for each procedure ranging from 75 for tetralogy of Fallot repair after prior palliation to 1104 for ventricular septal defect repairs (Figure). In aggregate, the unadjusted mortality ranged from 0% for ASD repair to 25.3% for Hybrid Stage I. There was significant heterogeneity in case volumes and unadjusted mortality for the different procedural categories across sites (e.g., ASO/VSD n=7 to 42, mortality 0% to 7%; Hybrid n=1 to 41, mortality 0% to 43%).

Conclusion: Reporting of institutional case volumes and outcomes, albeit unadjusted, within homogenous procedural categories will enable centers to benchmark their outcomes, better understand trends in mortality, and provides direction for improvement. Such analyses, when made public, will provide parents with information on a wide variety of specific operations. Including volumes of common operations will allow them to better understand each institution's experience with each operation. Future analysis will include adjustment for preoperative and patient-specific factors, which may allow for the development of prediction tools for outcomes that can aid counseling and setting of expectations not only for parents but also for the entire care team. 

View Submission


Invited Discussant

*Christopher Mascio, WVU Medicine Children's Hospital  - Contact Me Morgantown, WV 
United States

Abstract Presenter

*Meena Nathan, Boston Children's Hospital  - Contact Me Watertown, MA 
United States

108. A Novel Risk Prediction Model for 1-Year Mortality Following Congenital Heart Surgery − Analysis of >10,000 Patients Over 10 Years

Total Time: 15 Minutes 
Objective: Given the dearth of clinical prediction rules for mortality at one year following discharge from congenital heart surgery (CHS), we sought to develop a novel risk prediction model that accounts for clinical, anatomic, echocardiographic, and socioeconomic factors.
Methods: This was a single-center, retrospective review of consecutive patients who underwent CHS (the index operation) from 01/2011-01/2021 with known survival status at one year following discharge from the index hospitalization. The primary outcome was post-discharge mortality at one year. Variables of interest included age, prematurity, non-cardiac anomalies or syndromes, the Childhood Opportunity Index (COI, a US Census tract-based, nationally-normed composite metric of contemporary child neighborhood opportunity comprising 29 indicators across education, health/environment, and socioeconomic domains), STAT mortality category, major adverse postoperative complications (e.g., prolonged mechanical ventilation, renal failure, etc.), and the Residual Lesion Score (RLS, a quality improvement metric that assesses residual lesion severity at discharge based on echocardiographic criteria and pre-discharge unplanned reinterventions). Logistic regression models were used to develop a weighted risk score for the primary outcome. The final prediction model was internally validated using a bootstrapping resampling approach to estimate the optimism-corrected C-statistic based on 500 samples.
Results: Of 10,412 consecutive patients who were discharged following CHS, 8,827 (84.8%) met entry criteria. The median age was 1.9 (IQR 0.3-8.1) years. There were 195 (2.2%) deaths at one year post-discharge. Uni- and multivariable logistic regression models of the primary outcome are shown in Table 1. A weighted risk score was formulated based on the variables in the final risk prediction model (Table 1), which included all aforementioned factors of interest (this model had a C-statistic of 0.82, 95% CI 0.80-0.85). The median risk score was 7 (IQR 5-9) points. Patients were categorized as low (score 0-5), medium (score 6-10), high (score 11-15), or very high (score 16-20) risk for 1-year mortality. The predicted probability of mortality was 0.3 ± 0.1%, 1.5 ± 0.9%, 8.0 ± 4.3%, and 34.5 ± 8.2% for low, medium, high, and very high risk patients, respectively.
Conclusions: A risk prediction model of 1-year mortality may guide prognostication and follow-up of high-risk patients following discharge from CHS. 

View Submission


Invited Discussant

*Ram Kumar Subramanyan, Children’s Nebraska/University of Nebraska Medical Center  - Contact Me Omaha, NE 
United States

Abstract Presenter

Aditya Sengupta, Mount Sinai Health System  - Contact Me New York, NY 
United States

Partial Heart Transplant – Initial Experience

Total Time: 10 Minutes 

Speaker

*Joseph Turek, Duke University  - Contact Me Durham, NC 
United States

Partial Heart Transplant: What's All the Fuss About?

Total Time: 35 Minutes 

Panelist(s)

*Joseph Turek, Duke University  - Contact Me Durham, NC 
United States
*David Kalfa, Columbia University  - Contact Me new york, NY 
United States
Taufiek Rajab, Arkansas Children's Hospital  - Contact Me Little Rock, AR 
United States
Magdi Yacoub, National Heart and Lung Institute, Imperial College London  - Contact Me Harefield, Middlesex 
United Kingdom
Alexandra Glazier, New England Donor Services  - Contact Me Waltham, MA 
United States